Professor | Xu Yanjun | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Xu Yanjun

Contact Information

xuyanjun@hrbmu.edu.cn

Language ability

Chinese, English

Province

Heilongjiang

University/Lab Affiliation and Title	Harbin Medical University
Faculty	College of Bioinformatics Science and Technology
Awards	2019: Second Prize for Outstanding Scientific Research Achievements in Higher Education Institutions by the Ministry of Education of the People's Republic of China

University/Lab Affiliation and Title

Harbin Medical University

Faculty

College of Bioinformatics Science and Technology

Awards

2019: Second Prize for Outstanding Scientific Research Achievements in Higher Education Institutions by the Ministry of Education of the People's Republic of China

Areas of Focus	Non-coding RNA regulation and function in cancer Tumor drug resistance Single-cell data analysis
Publications	Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer, First Author, 2020 Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets, Corresponding Author, 2022 Comprehensive analysis of ncRNA involvement in brain microglia immunology, Corresponding Author, 2022 Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data, First Author, 2022 Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma, Corresponding Author, 2022 Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data, First Author, 2019 Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients, Corresponding Author, 2019 RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data, Co-First Author, 2020 A comprehensive overview of oncogenic pathways in human cancer, Co-First Author, 2020 Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma, Co-First Author, 2021

Areas of Focus

Non-coding RNA regulation and function in cancer
Tumor drug resistance
Single-cell data analysis

Publications

Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer, First Author, 2020
Identifying and characterizing drug sensitivity-related lncRNA-TF-gene regulatory triplets, Corresponding Author, 2022
Comprehensive analysis of ncRNA involvement in brain microglia immunology, Corresponding Author, 2022
Identifying individualized risk subpathways reveals pan-cancer molecular classification based on multi-omics data, First Author, 2022
Comprehensive analysis of microglia gene and subpathway signatures for glioma prognosis and drug screening: linking microglia to glioma, Corresponding Author, 2022
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data, First Author, 2019
Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients, Corresponding Author, 2019
RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data, Co-First Author, 2020
A comprehensive overview of oncogenic pathways in human cancer, Co-First Author, 2020
Dissecting immune cell stat regulation network reveals biomarkers to predict ICB therapy responders in melanoma, Co-First Author, 2021

Non-Coding Rna Cancer Regulation Function Tumor Drug Resistance Single-Cell Data Analysis Bioinformatics Genomics

Li Xia - Harbin Medical University

Xiao Yun - Harbin Medical University

Juan Xu - Harbin Medical University

View All

Personal Information